Background: Substance abuse frequently complicates the course of bipolar il
lness, promotes mixed states, and contributes to poor outcome in mania. Pre
liminary open trials suggest that anticonvulsant mood stabilizers may enhan
ce remission rates and outcome for bipolar patients with substance abuse. T
his study compared remission patterns for mixed or pure manic episodes amon
g bipolar inpatients with or without substance abuse histories.
Method: Hospital records were retrospectively reviewed far 204 DSM-LII-R bi
polar I inpatients. Clinical features were compared for those with or witho
ut substance abuse/dependence histories predating the index manic episode.
Time until remission was analyzed by Kaplan-Meier survival analysis. Natura
listic treatment outcome with lithium or anticonvulsant mood stabilizers wa
s compared for those with or without past substance abuse.
Results: Past substance abuse was evident in 34% of the bipolar sample and
comprised most often alcoholism (82%), followed by cocaine (30%), marijuana
(29%), sedative-hypnotic or amphetamine (21%), and opiate (13%) abuse. Sub
stance abuse was more common among men (p < .05) and those with mixed rathe
r than pure mania (p < .05). Remission during hospitalization was less like
ly among patients with prior substance abuse (p < .05), especially alcohol
or marijuana abuse, and among mixed manic patients with past substance abus
e (p < .05). Bipolar patients With substance abuse histories who received d
ivalproex or carbamazepine remitted during hospitalization more often than
did those who received lithium as the sole mood stabilizer (p < .05).
Conclusion: These findings support previous reports suggesting that bipolar
patients with past substance abuse have poorer naturalistic treatment outc
omes, but may show a better response to anticonvulsant mood stabilizers tha
n lithium.